These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 31522992)

  • 1. Cardio-oncology: Clinical and imaging perspectives for optimal cardiodetection and cardioprotection in patients with cancer.
    Thuny F; Huttin O; Ederhy S
    Arch Cardiovasc Dis; 2019 Oct; 112(10):550-558. PubMed ID: 31522992
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac Imaging in Oncology Patients in Europe: a Model for Advancement of CV Safety and Development of Comprehensive CV Care.
    López-Fernández T
    J Cardiovasc Transl Res; 2020 Jun; 13(3):490-494. PubMed ID: 32583314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodality Cardiac Imaging in the Era of Emerging Cancer Therapies.
    Biersmith MA; Tong MS; Guha A; Simonetti OP; Addison D
    J Am Heart Assoc; 2020 Jan; 9(2):e013755. PubMed ID: 31960741
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical Practice and Research in Cardio-Oncology: Finding the "Rosetta Stone" for Establishing Program Excellence in Cardio-oncology.
    Adusumalli S; Alvarez-Cardona J; Khatana SM; Mitchell JD; Blaes AH; Casselli SJ; O'Quinn R; Lenihan DJ
    J Cardiovasc Transl Res; 2020 Jun; 13(3):495-505. PubMed ID: 32444945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Cardiovascular Imaging and Serum Biomarkers in Identifying Cardiotoxicity Related to Cancer Therapeutics.
    Agha A; Zarifa A; Kim P; Iliescu C; Gladish G; Hassan S; Palaskas N; Durand JB; Lu Y; Lopez-Mattei J
    Methodist Debakey Cardiovasc J; 2019; 15(4):258-266. PubMed ID: 31988686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multilayer global longitudinal strain in patients with cancer: A comparison of two vendors.
    Ancedy Y; Ederhy S; Lang S; Hollebecque A; Dufour LS; Adavane-Scheuble S; Etienney A; Chauvet M; Soria JC; Cohen A
    Arch Cardiovasc Dis; 2018 Apr; 111(4):285-296. PubMed ID: 29422386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of cardiovascular magnetic resonance in cancer therapy-related cardiotoxicity.
    Miaris N; Kasinos N
    Int J Cardiovasc Imaging; 2024 Jun; 40(6):1393-1394. PubMed ID: 38613606
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic Imaging in Cardio-oncology.
    Tong D; Zaha VG
    J Cardiovasc Transl Res; 2020 Jun; 13(3):357-366. PubMed ID: 31696405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of echocardiography in the detection and the monitoring of left ventricular systolic dysfunction in patients undergoing cancer therapy].
    Charbonnel C
    Ann Cardiol Angeiol (Paris); 2020 Nov; 69(5):255-261. PubMed ID: 32962803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging in Cardio-Oncology: Where Are We and Where Should We Be Going?
    Steingart RM; Chandrashekhar Y; Marwick TH
    JACC Cardiovasc Imaging; 2018 Aug; 11(8):1209-1211. PubMed ID: 30092977
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardio-oncology: the role of advanced echocardiography in cancer patients.
    Venneri L; Zoppellaro G; Khattar RS
    Expert Rev Cardiovasc Ther; 2018 Apr; 16(4):249-258. PubMed ID: 29457984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Biomarkers in Cardio-Oncology.
    Ananthan K; Lyon AR
    J Cardiovasc Transl Res; 2020 Jun; 13(3):431-450. PubMed ID: 32642841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catching broken hearts: pre-clinical detection of doxorubicin and trastuzumab mediated cardiac dysfunction in the breast cancer setting.
    Saeed MF; Premecz S; Goyal V; Singal PK; Jassal DS
    Can J Physiol Pharmacol; 2014 Jul; 92(7):546-50. PubMed ID: 24959994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardio-Oncology: Progress in Diagnosis and Treatment of Cardiac Dysfunction.
    Tromp J; Steggink LC; Van Veldhuisen DJ; Gietema JA; van der Meer P
    Clin Pharmacol Ther; 2017 Apr; 101(4):481-490. PubMed ID: 28073142
    [No Abstract]   [Full Text] [Related]  

  • 15. Myocardial Strain Imaging by Echocardiography for the Prediction of Cardiotoxicity in Chemotherapy-Treated Patients: A Meta-Analysis.
    Ye L; Yang ZG; Selvanayagam JB; Luo H; Yang TZ; Perry R; Diao KY; Huang S; Yang MX; Yang P; Jin Y; Guo YK
    JACC Cardiovasc Imaging; 2020 Mar; 13(3):881-882. PubMed ID: 31734206
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardio-Oncology in 2020: Prime for Translation.
    Barac A
    J Cardiovasc Transl Res; 2020 Jun; 13(3):345-346. PubMed ID: 32495266
    [No Abstract]   [Full Text] [Related]  

  • 17. Echocardiography and Cardio-Oncology.
    Negishi T; Miyazaki S; Negishi K
    Heart Lung Circ; 2019 Sep; 28(9):1331-1338. PubMed ID: 31230869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of Cardiotoxicities With Traditional and Novel Chemotherapeutic Agents.
    Sharalaya Z; Collier P
    Curr Heart Fail Rep; 2018 Aug; 15(4):260-269. PubMed ID: 29938321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on cardio-oncology: Novel cancer therapeutics and associated cardiotoxicities.
    Guha A; Armanious M; Fradley MG
    Trends Cardiovasc Med; 2019 Jan; 29(1):29-39. PubMed ID: 29910109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs: novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart.
    Tocchetti CG; Ameri P; de Boer RA; D'Alessandra Y; Russo M; Sorriento D; Ciccarelli M; Kiss B; Bertrand L; Dawson D; Falcao-Pires I; Giacca M; Hamdani N; Linke WA; Mayr M; van der Velden J; Zacchigna S; Ghigo A; Hirsch E; Lyon AR; Görbe A; Ferdinandy P; Madonna R; Heymans S; Thum T
    Cardiovasc Res; 2020 Sep; 116(11):1820-1834. PubMed ID: 32683451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.